189 related articles for article (PubMed ID: 33653918)
41. Acute Myocarditis by Immune Checkpoint Inhibitor Identified by Quantitative Pixel-Wise Analysis of Native T1 Mapping.
Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Kishimoto M; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
Circ Cardiovasc Imaging; 2021 May; 14(5):e012177. PubMed ID: 33951932
[No Abstract] [Full Text] [Related]
42. Practical cardiovascular imaging approach to diagnose immune checkpoint inhibitor myocarditis.
Kondapalli L; Medina T; Groves DW
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):372-374. PubMed ID: 33367684
[TBL] [Abstract][Full Text] [Related]
43. Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
Wang F; Liu Y; Xu W; Zhang C; Lv J; Ma S
J Med Case Rep; 2021 Jul; 15(1):336. PubMed ID: 34225811
[TBL] [Abstract][Full Text] [Related]
44. [Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment].
Arangalage D; Pavon AG; Hugelshofer S; Desgraz B; Tzimas G; Delyon J; Muller O; Obeid M; Ribi C; Michielin O; Özdemir BC; Monney P
Rev Med Suisse; 2020 Jun; 16(696):1165-1168. PubMed ID: 32496706
[TBL] [Abstract][Full Text] [Related]
45. Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
Michel L; Totzeck M; Lehmann L; Finke D
Herz; 2020 Nov; 45(7):645-651. PubMed ID: 32533218
[TBL] [Abstract][Full Text] [Related]
46. A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma.
Iwasaki S; Hidaka H; Uojima H; Hashimura M; Nabeta T; Sanoyama I; Wada N; Kubota K; Nakazawa T; Shibuya A; Koizumi W
Clin J Gastroenterol; 2021 Aug; 14(4):1233-1239. PubMed ID: 34024039
[TBL] [Abstract][Full Text] [Related]
47. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
[TBL] [Abstract][Full Text] [Related]
48. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
Zhang L; Zlotoff DA; Awadalla M; Mahmood SS; Nohria A; Hassan MZO; Thuny F; Zubiri L; Chen CL; Sullivan RJ; Alvi RM; Rokicki A; Murphy SP; Jones-O'Connor M; Heinzerling LM; Barac A; Forrestal BJ; Yang EH; Gupta D; Kirchberger MC; Shah SP; Rizvi MA; Sahni G; Mandawat A; Mahmoudi M; Ganatra S; Ederhy S; Zatarain-Nicolas E; Groarke JD; Tocchetti CG; Lyon AR; Thavendiranathan P; Cohen JV; Reynolds KL; Fradley MG; Neilan TG
Circulation; 2020 Jun; 141(24):2031-2034. PubMed ID: 32539614
[No Abstract] [Full Text] [Related]
49. Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment.
Aghel N; Gustafson D; Di Meo A; Music M; Prassas I; Seidman MA; Hansen AR; Thavendiranathan P; Diamandis EP; Delgado D; Fish JE
JCO Precis Oncol; 2021 Mar; 5():. PubMed ID: 34337287
[No Abstract] [Full Text] [Related]
50. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
Lipe DN; Galvis-Carvajal E; Rajha E; Wechsler AH; Gaeta S
Am J Emerg Med; 2021 Aug; 46():51-55. PubMed ID: 33721590
[TBL] [Abstract][Full Text] [Related]
51. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
Prevel R; Colin G; Calès V; Renault PA; Mazieres J
Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
[TBL] [Abstract][Full Text] [Related]
52. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis.
Power JR; Alexandre J; Choudhary A; Ozbay B; Hayek S; Asnani A; Tamura Y; Aras M; Cautela J; Thuny F; Gilstrap L; Arangalage D; Ewer S; Huang S; Deswal A; Palaskas NL; Finke D; Lehman L; Ederhy S; Moslehi J; Salem JE;
Circulation; 2021 Nov; 144(18):1521-1523. PubMed ID: 34723640
[No Abstract] [Full Text] [Related]
53. Immune checkpoint inhibitor myocarditis: a call for standardized histopathologic criteria.
Rizzo S; De Gaspari M; Basso C
Eur J Heart Fail; 2021 Oct; 23(10):1736-1738. PubMed ID: 34263962
[No Abstract] [Full Text] [Related]
54. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Aldrich J; Pundole X; Tummala S; Palaskas N; Andersen CR; Shoukier M; Abdel-Wahab N; Deswal A; Suarez-Almazor ME
Arthritis Rheumatol; 2021 May; 73(5):866-874. PubMed ID: 33258544
[TBL] [Abstract][Full Text] [Related]
55. Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy.
Schiffer WB; Deych E; Lenihan DJ; Zhang KW
Int J Cardiol; 2021 Jan; 322():177-182. PubMed ID: 32800916
[TBL] [Abstract][Full Text] [Related]
56. Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
Alhumaid W; Yogasundaram H; Senaratne JM
Eur Heart J; 2021 Jul; 42(29):2868. PubMed ID: 33829266
[No Abstract] [Full Text] [Related]
57. Immune checkpoint inhibitor-related myocarditis.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2018 Jan; 48(1):7-12. PubMed ID: 29045749
[TBL] [Abstract][Full Text] [Related]
58. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity.
Zarifa A; Lopez-Mattei J; Palaskas N; Iliescu C; Durand JB; Kim PY
Adv Exp Med Biol; 2020; 1244():277-285. PubMed ID: 32301022
[TBL] [Abstract][Full Text] [Related]
59. [A case report of immune checkpoint inhibitor-induced myocarditis].
Liao HL; Chen DD; Pan Y; Liu ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):710-712. PubMed ID: 35856230
[TBL] [Abstract][Full Text] [Related]
60. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.
Awadalla M; Mahmood SS; Groarke JD; Hassan MZO; Nohria A; Rokicki A; Murphy SP; Mercaldo ND; Zhang L; Zlotoff DA; Reynolds KL; Alvi RM; Banerji D; Liu S; Heinzerling LM; Jones-O'Connor M; Bakar RB; Cohen JV; Kirchberger MC; Sullivan RJ; Gupta D; Mulligan CP; Shah SP; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Lawrence DP; Mahmoudi M; Devereux RB; Forrestal BJ; Mandawat A; Lyon AR; Chen CL; Barac A; Hung J; Thavendiranathan P; Picard MH; Thuny F; Ederhy S; Fradley MG; Neilan TG
J Am Coll Cardiol; 2020 Feb; 75(5):467-478. PubMed ID: 32029128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
